| [1] |
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5):E359-386.
|
| [2] |
de Martel C, Maucort-Boulch D, Plummer M, et al. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma[J]. Hepatology, 2015, 62(4):1190-1200.
|
| [3] |
Yates LA, Norbury CJ, Gilbert RJ. The long and short of microRNA[J]. Cell, 2013, 153(3):516-519.
|
| [4] |
钟阿红，郁春晴，董春林，等．miR-124在消化系统肿瘤研究中的进展[J]．现代生物医学进展，2016，16(9):1741, 1759-1761.
|
| [5] |
Filios SR, Shalev A. β-Cell microRNAs: small but powerful[J]. Diabetes, 2015, 64(11):3631-3644.
|
| [6] |
吕细林，黄刚，肖曼，等．过表达长链非编码RNA H19促进miR-124-3p表达抑制肝癌细胞增殖[J]．第三军医大学学报，2016，38(6):554-559.
|
| [7] |
Zundler S, Neurath MF. Integrating immunologic signaling networks: the JAK/STAT pathway in colitis and colitis-associated cancer[J]. Vaccines, 2016, 4(1):E5.
|
| [8] |
Lu Y, Yue X, Cui Y, et al. MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3[J]. Biochem Biophys Res Commun, 2013, 441(4):873-879.
|
| [9] |
LoRusso PM. Inhibition of the PI3K/AKT/mTOR pathway in solid tumors[J]. J Clin Oncol, 2016, 34(31):3803-3815.
|
| [10] |
Lang Q, Ling C. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA[J]. Biochem Biophys Res Commun, 2012, 426(2):247-252.
|
| [11] |
Zevian SC, Johnson JL, Winterwood NE, et al. CD151 promotes α3β1 integrin-dependent organization of carcinoma cell junctions and restrains collective cell invasion[J]. Cancer Biol Ther, 2015, 16(11):1626-1640.
|
| [12] |
Liu T, Zu CH, Wang SS, et al. PIK3C2A mRNA functions as a miR-124 sponge to facilitate CD151 expression and enhance malignancy of hepatocellular carcinoma cells[J]. Oncotarget, 2016, 7(28):43376-43389.
|
| [13] |
Yang ZP, Ma HS, Wang SS, et al. LAMC1 mRNA promotes malignancy of hepatocellular carcinoma cells by competing for MicroRNA-124 binding with CD151[J]. IUBMB Life, 2017, 69(8):595-605.
|
| [14] |
Kwakwa KA, Sterling JA. Integrin αvβ3 signaling in tumor-induced bone disease[J]. Cancers, 2017, 9(7):E84.
|
| [15] |
Cai QQ, Dong YW, Wang R, et al. MiR-124 inhibits the migration and invasion of human hepatocellular carcinoma cells by suppressing integrin αV expression[J]. Sci Rep, 2017(7):40733.
|
| [16] |
Zheng F, Liao YJ, Cai MY, et al. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2[J]. Gut, 2012, 61(2):278-289.
|
| [17] |
Hartmann S, Ridley AJ, Lutz S. The function of Rho-associated kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease[J]. Front Pharmacol, 2015(6):276.
|
| [18] |
郑礼平，李志花，陈汝福，等．SMYD3过表达对人肝内胆管癌细胞miR-124表达及细胞增殖的影响[J]．中国病理生理杂志，2013，29(1):76-80.
|
| [19] |
Anwar SL, Albat C, Krech T, et al. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker[J]. Int J Cancer, 2013, 133(3):660-670.
|
| [20] |
Xu L, Dai W, Li J, et al. Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3[J]. Oncotarget, 2016, 7(18):26027-26041.
|
| [21] |
Ning BF, Ding J, Liu J, et al. Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression[J]. Hepatology, 2014, 60(5):1607-1619.
|